J Exp Clin Cancer Res. 2024 Apr 23;43(1):123.doi: 10.1186/s13046-024-03048-1. (IF:12.658).
2024-04-07J Exp Clin Cancer Res. 2024 Apr 23;43(1):123.doi: 10.1186/s13046-024-03048-1. Tumor-suppressive miR-4732-3p is sorted into fucosylated exosome by hnRNPK to avoid the inhibition of lung cancer progression (IF:12.658).肿瘤抑制性miR-4732-3p通过hnRNPK分类为岩藻糖基外泌体,以避免对肺癌癌症进展的抑制